Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Entheon Biomedical (ENTBF)
OTHER OTC:ENTBF
Entheon Biomedical (ENTBF) Stock Price & Analysis
33 Followers
ENTBF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.02 - $0.25
Previous Close$0.09
Volume1.00
Average Volume (3M)1.91K
Market Cap
$485.84K
Enterprise Value$303.15K
Total Cash (Recent Filing)C$249.92K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.27
Next Earnings
Oct 24, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding8,858,926
10 Day Avg. Volume2,696
30 Day Avg. Volume1,909
Standard Deviation0.33
R-Squared0.16
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)3.53
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Entheon Biomedical News
PremiumCompany Announcements
Entheon Biomedical Completes $147.5K Private Placement
PremiumCompany Announcements
Entheon Biomedical’s Strategic Financing InitiativeOptions Prices
Currently, No data available
---
Ownership Overview
58.40% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
41.60% Public Companies and
Individual Investors
ENTBF FAQ
What was Entheon Biomedical’s price range in the past 12 months?
Entheon Biomedical lowest stock price was $0.02 and its highest was $0.25 in the past 12 months.
What is Entheon Biomedical’s market cap?
Currently, no data Available
When is Entheon Biomedical’s upcoming earnings report date?
Entheon Biomedical’s upcoming earnings report date is Oct 24, 2024 which is in 99 days.
How were Entheon Biomedical’s earnings last quarter?
Entheon Biomedical released its earnings results on Jul 04, 2024. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.
Is Entheon Biomedical overvalued?
According to Wall Street analysts Entheon Biomedical’s price is currently Overvalued.
Does Entheon Biomedical pay dividends?
Entheon Biomedical does not currently pay dividends.
What is Entheon Biomedical’s EPS estimate?
Entheon Biomedical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Entheon Biomedical have?
Entheon Biomedical has 8,858,926 shares outstanding.
What happened to Entheon Biomedical’s price movement after its last earnings report?
Entheon Biomedical reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 16.667%.
Which hedge fund is a major shareholder of Entheon Biomedical?
Currently, no hedge funds are holding shares in ENTBF
---
Entheon Biomedical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
-81.49%
12-Months-Change
Fundamentals
Return on Equity
-87.35%
Trailing 12-Months
Asset Growth
-41.77%
Trailing 12-Months
Company Description
Entheon Biomedical
Entheon Biomedical Corp is a biotechnology research and development company. It is committed towards developing and safe and effective psychedelic medicines in order to provide patients with access to evidence-based treatments for addiction disorders. It generates revenue through the sale of products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.
---
Technical Analysis
---